Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis Stancato

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Current Opinion in Drug Discovery & Development|April 23, 2008
Prioritizing hits from phenotypic high-content screensJonathan Low, Louis Stancato, Jonathan Lee, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|March 25, 2020
Crossing Oceans: Preclinical Collaboration to Improve Pediatric Drug DevelopmentGregory Reaman, Louis Stancato, Gilles Vassal, et al.
Molecular Cancer Therapeutics|August 30, 2008
High-content imaging characterization of cell cycle therapeutics through in vitro and in vivo subpopulation analysisJonathan Low, Shuguang Huang, Wayne Blosser, et al.
Current Chemical Genomics|February 18, 2010
Phenotypic fingerprinting of small molecule cell cycle kinase inhibitors for drug discoveryJonathan Low, Arunava Chakravartty, Wayne Blosser, et al.
Assay and Drug Development Technologies|April 20, 2004
Development of displacement binding and GTPgammaS scintillation proximity assays for the identification of antagonists of the micro-opioid receptorGeorge Rodgers, Cassandra Hubert, Jamie McKinzie, et al.
The Journal of Biological Chemistry|January 22, 2013
LY2228820 dimesylate, a selective inhibitor of p38 mitogen-activated protein kinase, reduces angiogenic endothelial cord formation in vitro and in vivoCourtney M Tate, Wayne Blosser, Lisa Wyss, et al.
Journal of Biomolecular Screening|September 30, 2011
Knockdown of ubiquitin ligases in glioblastoma cancer stem cells leads to cell death and differentiationJonathan Low, Wayne Blosser, Michele Dowless, et al.
Plos One|April 25, 2014
A method to assess target gene involvement in angiogenesis in vitro and in vivo using lentiviral vectors expressing shRNAWayne Blosser, Eliza Vakana, Lisa V Wyss, et al.
Journal of Biomolecular Screening|July 20, 2010
Knockdown of cancer testis antigens modulates neural stem cell marker expression in glioblastoma tumor stem cellsJonathan Low, Michele Dowless, Tatiyana Shiyanova, et al.
Journal of Biomolecular Screening|May 23, 2007
High-content imaging analysis of the knockdown effects of validated siRNAs and antisense oligonucleotidesJonathan Low, Shuguang Huang, Michele Dowless, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Current Opinion in Drug Discovery & Development|April 23, 2008
Prioritizing hits from phenotypic high-content screensJonathan Low, Louis Stancato, Jonathan Lee, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|March 25, 2020
Crossing Oceans: Preclinical Collaboration to Improve Pediatric Drug DevelopmentGregory Reaman, Louis Stancato, Gilles Vassal, et al.
Molecular Cancer Therapeutics|August 30, 2008
High-content imaging characterization of cell cycle therapeutics through in vitro and in vivo subpopulation analysisJonathan Low, Shuguang Huang, Wayne Blosser, et al.
Current Chemical Genomics|February 18, 2010
Phenotypic fingerprinting of small molecule cell cycle kinase inhibitors for drug discoveryJonathan Low, Arunava Chakravartty, Wayne Blosser, et al.
Assay and Drug Development Technologies|April 20, 2004
Development of displacement binding and GTPgammaS scintillation proximity assays for the identification of antagonists of the micro-opioid receptorGeorge Rodgers, Cassandra Hubert, Jamie McKinzie, et al.
The Journal of Biological Chemistry|January 22, 2013
LY2228820 dimesylate, a selective inhibitor of p38 mitogen-activated protein kinase, reduces angiogenic endothelial cord formation in vitro and in vivoCourtney M Tate, Wayne Blosser, Lisa Wyss, et al.
Journal of Biomolecular Screening|September 30, 2011
Knockdown of ubiquitin ligases in glioblastoma cancer stem cells leads to cell death and differentiationJonathan Low, Wayne Blosser, Michele Dowless, et al.
Plos One|April 25, 2014
A method to assess target gene involvement in angiogenesis in vitro and in vivo using lentiviral vectors expressing shRNAWayne Blosser, Eliza Vakana, Lisa V Wyss, et al.
Journal of Biomolecular Screening|July 20, 2010
Knockdown of cancer testis antigens modulates neural stem cell marker expression in glioblastoma tumor stem cellsJonathan Low, Michele Dowless, Tatiyana Shiyanova, et al.
Journal of Biomolecular Screening|May 23, 2007
High-content imaging analysis of the knockdown effects of validated siRNAs and antisense oligonucleotidesJonathan Low, Shuguang Huang, Michele Dowless, et al.
Pageof 2